Olinciguat
C1701-201
Phase 2 small_molecule terminated
Quick answer
Olinciguat for Achalasia is a Phase 2 program (small_molecule) at Cyclerion Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cyclerion Therapeutics
- Indication
- Achalasia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated